TrianglePUBLICATIONS · 34865212
Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Haematol
- Publication date
- 2022 Feb
- First author
- Allan JN
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Allan JN
- type
- Author
- name
- Shanafelt T
- type
- Author
- name
- Wiestner A
- type
- Author
- name
- Moreno C
- type
- Author
- name
- O'Brien SM
- type
- Author
- name
- Li J
- type
- Author
- name
- Krigsfeld G
- type
- Author
- name
- Dean JP
- type
- Author
- name
- Ahn IE
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Allan JN
- type
- Author
- name
- Shanafelt T
- type
- Author
- name
- Wiestner A
- type
- Author
- name
- Moreno C
- type
- Author
- name
- O'Brien SM
- type
- Author
- name
- Li J
- type
- Author
- name
- Krigsfeld G
- type
- Author
- name
- Dean JP
- type
- Author
- name
- Ahn IE
- type
- Author
- bibliography ids
- nci-bib-e361325ee131a6a45518c8f6
- book metadata
- content sha256
- a7c25f09147cf5f34add0afcaa8494fc6927a38eaf3b0f7d517d853b4fcae139
- document type
- citation
- dois
- 10.1111/bjh.17984
- electronic publication date
- display
- 2021 Dec 5
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34865212
- immutable id
- pubmed:34865212@a7c25f09147cf5f34add0afcaa8494fc6927a38eaf3b0f7d517d853b4fcae139
- journal
- abbreviation
- Br J Haematol
- issn electronic
- 1365-2141
- issn print
- 0007-1048
- issue
- 4
- name
- British journal of haematology
- nlm unique id
- 0372544
- pages
- 947-953
- volume
- 196
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34865212
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- 62b757f65b09f944d4e16b79de2dbb176466100e9e8037a63998afef3b104d46
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2022 Feb
- precision
- month
- year
- 2022
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials.
Preserved source evidence · Not medical advice